KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Amortizatization of Intangibles: 2009-2024

Historic Amortizatization of Intangibles for Pacira BioSciences (PCRX) over the last 16 years, with Dec 2024 value amounting to $92,000.

  • Pacira BioSciences' Amortizatization of Intangibles rose 143.48% to $56,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $123,000, marking a year-over-year increase of 30.85%. This contributed to the annual value of $92,000 for FY2024, which is 87.77% down from last year.
  • Latest data reveals that Pacira BioSciences reported Amortizatization of Intangibles of $92,000 as of FY2024, which was down 87.77% from $752,000 recorded in FY2023.
  • In the past 5 years, Pacira BioSciences' Amortizatization of Intangibles ranged from a high of $23.2 million in FY2021 and a low of $92,000 during FY2024.
  • For the 3-year period, Pacira BioSciences' Amortizatization of Intangibles averaged around $1.2 million, with its median value being $752,000 (2023).
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first surged by 32.79% in 2020, then slumped by 87.88% in 2022.
  • Over the past 5 years, Pacira BioSciences' Amortizatization of Intangibles (Yearly) stood at $18.3 million in 2020, then rose by 26.83% to $23.2 million in 2021, then slumped by 87.88% to $2.8 million in 2022, then slumped by 73.21% to $752,000 in 2023, then slumped by 87.77% to $92,000 in 2024.